title: Comparing topical scabietic treatments will soon become extinct.
authors.forename: K M
authors.initials: KM
authors.lastname: Burkhart
authors.forename: C N
authors.initials: CN
authors.lastname: Burkhart
authors.forename: C G
authors.initials: CG
authors.lastname: Burkhart
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D018118:Chloride Channels / Q000187:drug effects; D017277:Drug Approval; D006734:Horse Diseases / Q000188:drug therapy; D006736:Horses; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012532:Scabies / Q000188:drug therapy* / Q000662:veterinary; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000871:Anthelmintics; D018118:Chloride Channels; D007559:Ivermectin